Unknown

Dataset Information

Application of multi-state models in cancer clinical trials.


ABSTRACT: Background/aims The goal of this article is to illustrate the utility of multi-state models in cancer clinical trials. Our specific aims are to describe multi-state models and how they differ from standard survival methods, to illustrate how multi-state models can facilitate deeper understanding of the treatment effect on multiple paths along the disease process that patients could experience in cancer clinical trials, to explain the differences between multi-state models and time-dependent Cox models, and to briefly describe available software to conduct such analyses. Methods Data from 717 newly diagnosed acute myeloid leukemia patients who enrolled in the CALGB 10603 trial were used as an illustrative example. The current probability-in-state was estimated using the Aalen-Johansen estim

SUBMITTER: Le-Rademacher JG 

PROVIDER: S-EPMC6133743 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature